Esophageal Cancer: Profile of Clinical Manifestations, Histology, Location and Metastatic Behavior in Patients Undergoing Cancer Treatment at a Cancer Center in Minas Gerais

Authors

  • Nonato Mendonça Lott Monteiro Estudante do 12º período da Faculdade de Medicina do Vale do Aço e estagiário do departamento de Radioterapia do Centro de Oncologia e Radioisótopos de Ipatinga (MG), Brasil
  • Daniel Francisco de Araújo Estudante do 12º período da Faculdade de Medicina da UNIPAC/Barbacena (MG), Brasil
  • Eric Bassetti-Soares Médico, Doutor em Gastroenterologista, Professor e Coordenador de Pesquisa da Faculdade de Medicina do Vale do Aço, Ipatinga (MG), Brasil
  • José Pedro Ferreira de Bastos Vieira Médico Radioterapeuta do Centro de Oncologia e Radioisótopos de Ipatinga (MG), Brasil
  • Marcos Rivânio Marinho dos Santos Estudante do 8º período do curso de Biomedicina da UNIPAC/Ipatinga (MG), Brasil
  • Pedro Paulo Lopes de Oliveira Júnior Médico Radioterapeuta do Centro de Oncologia e Radioisótopos de Ipatinga (MG), Brasil
  • Tatiana Siqueira Jacques Delgado Estudante do 12º período da Faculdade de Medicina do Vale do Aço e estagiário do departamento de Radioterapia do Centro de Oncologia e Radioisótopos de Ipatinga (MG), Brasil

DOI:

https://doi.org/10.32635/2176-9745.RBC.2009v55n1.1673

Keywords:

Esophageal Neoplasms, Neoplasm metastasis, Histology

Abstract

Esophageal cancer (EC) is a type of tumor with an increasing incidence, and mortality rates close to incidence rates. Its etiology is associated with the histological type of the disease, with the squamous cell carcinoma as the most common and strongly related to smoking and alcoholic habits, as well as the adenocarcinoma associated with Barrett's esophagus. In addition to these well-known factors, the risk of developing this cancer is increased in people who ingest food and hot drinks (mate) and who have poor nutrition (hipovitaminose A, C and E); also, there is a genetic predisposition that is still poorly defined. Clinical manifestations common during the evolution of this disease include dysphagia, odynophagia, retroesternal discomfort, hiporexia, nausea, vomiting, weight loss. Such complaints deserve careful evaluation because when revealed, the disease is already, in most cases, in an advanced stage and a curative approach on these patients is not possible. Protocols for the EC treatment include surgery, chemotherapy and radiotherapy, but the best treatment is still cause for studies. This study aims to describe and analyze the profile of clinical manifestations, the relationship between the histological type and the location, age and metastatic behavior and therapy of patients with EC undergoing cancer treatment at the Oncology and Radioisotopes Center (COR), Ipatinga-MG. Retrospective analysis of records of 109 patients diagnosed with EC was made, from May 2004 to February 2007. For statistical calculations the program Epi Info 6.04d was used.

Downloads

Download data is not yet available.

Published

2009-03-31

How to Cite

1.
Monteiro NML, Araújo DF de, Bassetti-Soares E, Vieira JPF de B, Santos MRM dos, Oliveira Júnior PPL de, Delgado TSJ. Esophageal Cancer: Profile of Clinical Manifestations, Histology, Location and Metastatic Behavior in Patients Undergoing Cancer Treatment at a Cancer Center in Minas Gerais. Rev. Bras. Cancerol. [Internet]. 2009 Mar. 31 [cited 2024 May 14];55(1):27-32. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/1673

Issue

Section

ORIGINAL ARTICLE

Most read articles by the same author(s)